medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2018, Number 1

<< Back

Acta Med Cent 2018; 12 (1)

Neumonía organizativa criptógena

García EC, Philip N, Santos PLA, Fernández REG, Santos TY, Hernández NH, Carballo FM, Inampué FYC, Mederos ME, Gutiérrez HAE, Olivera EAJ

Language: Spanish
References: 10
Page: 104-123
PDF size: 2195.80 Kb.


ABSTRACT

Male patient of 74 years old, with personal pathological histories of obesity, hypertension, diabetes mellitus and left branch block of the bundle of His. He began with dyspnea and dry cough that did not improve with the treatment imposed by the family doctor. He went to the Cardiocentro “Ernesto Che Guevara” and carried out complementary tests: hemoglobin (low figures), creatinine and uric acid (elevated), from where he was referred to “Arnaldo Milián Castro” Hospital Guardhouse: bibasal crackles were heard in the respiratory system, systolic murmur II/VI in aortic and pulmonary focus and edema of the lower limbs; a chest x-ray showed cottony speckling on both lung bases and an echocardiogram signs of severe pulmonary hypertension. He was admitted with diagnoses of chronic kidney disease due to diabetic nephropathy and arterial hypertension; he evolved poorly, he did not respond to the treatments and died of respiratory failure 18 days after admission. The findings at necropsy allowed the diagnosis of decompensated chronic cor pulmonale in a patient suffering from severe pulmonary hypertension due to cryptogenic organizing pneumonia as a basic cause of death.


REFERENCES

  1. Fukuoka J. Chronic Diffuse Lung Diseases. En: Leslie KO, Wick MR. Practical pulmonary pathology: a diagnostic approach Philadelphia, PA: Elsevier; 2011. p. 213-225.

  2. Corrin B, Nicholson AG. Alveolar filling defects. En: Pathology of lungs chapter. 3ra ed. London: Churchill Livingstone; 2011 p. 308-311.

  3. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins y Cotran Patología estructural y funcional. 8va ed. España: Elsevier; 2010.

  4. Simonneau G, Galie N, Rubin LJ. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004 Jun 16;43 (12 Suppl S):5S-12S.

  5. Montani D, Achouh L, Dorfmuller P. Pulmonary veno occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008 Jul;87(4):220-33. doi: 10.1097/MD.0b013e31818193bb.

  6. Dorfmuller P, Humbert M, Perros F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol. 2007 Jun;38(6):893-902. Epub 2007 Mar 21.

  7. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax [Internet]. 2005 Jul [citado 10 Sept];60(7):605-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15994270

  8. Shorr AF, Wainright JL, Cors CS. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J. 2007 Oct;30(4):715-21. Epub 2007 Jul 11.

  9. Badesch DB, Abman SH, Simonneau G. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence based clinical practice guidelines. Chest [Internet]. 2007 Jun [citado 10 Sept];131(6):1917–1928. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/17565025

  10. 10.Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med [Internet]. 2004 Sep 30 [citado 10 Sept];351(14):1425-36. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15459304




2020     |     www.medigraphic.com